Hepatitis. Invest US$ 6 bn per year to save 30 Million lives

11.08.2019 - New York - REHUNO - Red Humanista de Noticias en Salud

This post is also available in: Spanish, French, Portuguese

Hepatitis. Invest US$ 6 bn per year to save 30 Million lives

“WHO urges countries to invest in eliminating hepatitis”

WHO calls on countries to take advantage of recent reductions in the costs of diagnosing and treating viral hepatitis and scale up investments in disease elimination.

A new study by WHO, published in Lancet Global Health, has found that investing US$6bn per year in eliminating hepatitis in 67 low- and middle-income countries  would avert 4.5 million premature deaths by 2030, and more than 26 million deaths beyond that target date.

A total of US$58.7 billion is needed to eliminate viral hepatitis as a public health threat in these 67 countries by 2030. This means reducing new hepatitis infections by 90% and deaths by 65%.

“Today 80% of people living with hepatitis can’t get the services they need to prevent, test for and treat the disease,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “On World Hepatitis Day, we’re calling for bold political leadership, with investments to match. We call on all countries to integrate services for hepatitis into benefit packages as part of their journey towards universal health coverage.”

By investing in diagnostic tests and medicines for treating hepatitis B and C now, countries can save lives and reduce costs related to long-term care of cirrhosis and liver cancer that result from untreated hepatitis.

Categories: Health, International
Tags: ,

Newsletter

Enter your e-mail address to subscribe to our daily news service.

Search

Hiroshima-Nakasaki, August 6th-9th, 1945

75th Anniversary Of Nuclear Bombings

Documentaries Catalogue

In Mobilization For Assange!

International Campaign to Abolish Nuclear Weapons

International Campaign to Abolish Nuclear Weapons

Archives

xpornplease pornjk porncuze porn800 porn600 tube300 tube100 watchfreepornsex

Except where otherwise note, content on this site is licensed under a Creative Commons Attribution 4.0 International license.